| |||||
       
Bertalan Mesko,MD,PhD    Alzheimer's Disease Education & Referral Center  Colorectal Cancer Screen  CDC.gov  
 | Objectives This study sought to compare the action of prasugrel and ticagrelor in ST-segment elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PPCI). Background It has been documented that prasugrel and ticagrelor are able to provide effective platelet inhibition 2 h after a loading dose (LD). However,the pharmacodynamic measurements after prasugrel [...] Objectives The aim of the AIDA STEMI (Abciximab i.v. Versus i.c. in ST-elevation Myocardial Infarction) cardiac magnetic resonance (CMR) substudy was to investigate potential benefits of intracoronary versus intravenous abciximab bolus administration on infarct size and reperfusion injury in ST-segment elevation myocardial infarction. Background The AIDA STEMI trial randomized 2,065 patients to intracoronary or [...] The intravenous (IV) route is the standard way to administer abciximab to patients during percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI),but pharmacokinetic principles predict that the intracoronary (IC) route would be better. Because of the short half-life of abciximab and its avid binding to multiple integrin types during the first pass [...] Most Viewed:NEJM Most Viewed Articles –Week Objectives The purpose of this study was to determine the consistency of the effects of radial artery access in patients with ST-segment elevation myocardial infarction (STEMI) and in those with non–ST-segment elevation acute coronary syndrome (NSTEACS). Background The safety associated with radial access may translate into mortality benefit in higher-risk patients,such as those [...] Abstract:Background:Young patients (aged≤45 years) presenting with ST-segment elevation myocardial infarction present unique challenges. The quality of care and in-hospital outcomes may differ from their older counterparts. Methods:A total of 31,544 patients presenting with ST-segment elevation myocardial infarction and enrolled in the American Heart Association’s Get With the Guidelines Coronary Artery Disease registry [...] Objectives This study sought to measure the impact of pre-hospital (PH) electrocardiography (ECG) on scene-to-hospital time for patients with chest pain of cardiac origin and those with ST-segment elevation myocardial infarction (STEMI). Background Pre-hospital ECG decreases door-to balloon (D2B) time for STEMI patients. However,obtaining a PH ECG might prolong scene time. We investigated [...] Objectives The aim of this study was to investigate the prognostic role of neutrophil gelatinase–associated lipocalin (NGAL) in a large population of patients with ST-segment elevation myocardial infarction. Background NGAL is a glycoprotein released by damaged renal tubular cells and is a sensitive maker of both clinical and subclinical acute kidney injury. New data [...] Journal of the American College of Cardiology current issue |
  --------------------------------------
University of Washington - Seattle,WA --------------------------------------  --------------------------------------  University of Washington - Harborview Medical CenterSeattle,WA   Office on Women's Health U.S. Department of Health and Human Services      "Watch your weight & your waist!"     CDC:Public Health
  
 U.S. Department of Health & Human ServicesNational Health Information Center
  | |||
| Copyright © 2013 Knowledge of Medicine - All Rights Reserved | Mission Statement | About Us | Contact Us | Hosted &Designed Whelan Technologies | Submit an Article | | |||||
